Company news
Drugs Made In America Acquisition Ii Corp. (NASDAQ:DMII) news
Drugs Made In America Acquisition Ii Corp. news releases on 6ix. Latest, May 14, 2026: Drugs Made In America Acquisition II Corp. 1Q 2026: Net income $4.34M…
Press releases & updates
Drugs Made In America Acquisition II Corp. 1Q 2026: Net income $4.34M, EPS $0.07— 10-Q Summary
May 14, 2026
Drugs Made In America Acquisition II 10-K: Net income $4.19M, Net loss $0.15M
April 15, 2026
Drugs Made In America Acquisition II Finalizes $1.4M Notes Deal, Adds $300K Interim Convertible
April 3, 2026
Drugs Made In America Acquisition II Secures $150,000 Convertible Bridge Note From Alpha Multi Family Office
March 17, 2026
Drugs Made In America appoints Roger Bendelac as CEO after Lynn Stockwell resignation
March 6, 2026